comparemela.com

Latest Breaking News On - Program at massachusetts - Page 1 : comparemela.com

STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports

In conducting the “Statins to Prevent the Cardiotoxicity from Anthracyclines: The STOP-CA Trial,” researchers found that among people receiving chemotherapy regimens containing anthracyclines for lymphoma, those who took the cholesterol-lowering drug atorvastatin for one year were significantly less likely to show evidence of heart dysfunction than those who took a placebo. FIndings were reported during the first late-breaking clinical trial session during the March 4-6 American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC.

Former Chairperson of the American Academy of Pediatrics, Dr Susan Baker joins Else s Scientific Advisory Board

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.